Cargando…

Prognostic Assessment in Patients with Indolent B-Cell Lymphomas

Follicular lymphoma (FL) is an indolent lymphoma with long median survival. Many studies have been performed to build up prognostic scores potentially useful to identify patients with poorer outcome. In 2004, an international consortium coordinated by the International Follicular Lymphoma Prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arcaini, Luca, Rattotti, Sara, Gotti, Manuel, Luminari, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417199/ https://www.ncbi.nlm.nih.gov/pubmed/22919288 http://dx.doi.org/10.1100/2012/107892

Ejemplares similares

Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
por: Arcaini, Luca, et al.
Publicado: (2012)

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
por: Merli, Michele, et al.
Publicado: (2016)

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus–Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi
por: Merli, Michele, et al.
Publicado: (2022)

B‐cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non‐Hodgkin's Lymphoma
por: Gragnani, Laura, et al.
Publicado: (2022)

Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy
por: Colaneri, Marta, et al.
Publicado: (2022)

Treatment of indolent lymphoma
por: Jeong, Seong Hyun
Publicado: (2022)

How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
por: Lumish, Melissa, et al.
Publicado: (2021)

Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
por: Minson, Adrian, et al.
Publicado: (2022)

Primary cutaneous B‐cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers
por: Lucioni, Marco, et al.
Publicado: (2016)

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
por: Morello, Lucia, et al.
Publicado: (2019)

Prognostic tools for older patients with diffuse large B-cell lymphoma: complex patients require complex solutions and a personal touch
por: Luminari, Stefano
Publicado: (2023)

The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas
por: Artemaki, Pinelopi I., et al.
Publicado: (2021)

Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study
por: Zuccaro, Valentina, et al.
Publicado: (2023)

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's Lymphomas
por: Gunnellini, Marco, et al.
Publicado: (2012)

Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
por: Menzer, Christian, et al.
Publicado: (2022)

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma
por: Daniel, Adrien, et al.
Publicado: (2022)

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
por: Madanat, Yazan F, et al.
Publicado: (2016)

Follicular lymphoma - treatment and prognostic factors
por: Luminari, Stefano, et al.
Publicado: (2012)

Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract (iTLPD-GI): A Review
por: Sanguedolce, Francesca, et al.
Publicado: (2021)

Rare concurrent indolent B-cell lymphoma and plasmablastic transformation of myeloma
por: Saburi, Masuho, et al.
Publicado: (2018)

Novel prognostic tools that identify high-risk follicular lymphoma
por: Luminari, Stefano
Publicado: (2019)

Prognostic Impact of Muscle Quantity and Quality and Fat Distribution in Diffuse Large B-Cell Lymphoma Patients
por: Besutti, Giulia, et al.
Publicado: (2021)

Light Chain Crystal Podocytopathy in a Patient With Systemic Indolent B-Cell Lymphoma
por: Kamar, Fareed, et al.
Publicado: (2019)

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
por: Pileri, Stefano A., et al.
Publicado: (2021)

Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma
por: Kameda, Takuro, et al.
Publicado: (2022)

The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma
por: Aldoss, Ibrahim T, et al.
Publicado: (2009)

Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023)

Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma
por: Takahashi, Naoki, et al.
Publicado: (2021)

Indolent primary effusion lymphoma
por: Nagrale, Vidya, et al.
Publicado: (2020)

Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma
por: Yoshino, Tadashi, et al.
Publicado: (2020)

Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation
por: Arboe, Bente, et al.
Publicado: (2017)

Indolent T‐cell‐rich small B‐cell hepatic lymphoma in a Golden Retriever
por: Rout, Emily D., et al.
Publicado: (2018)

Bendamustine: Safety and Efficacy in the Management of Indolent Non-Hodgkins Lymphoma
por: Tageja, Nishant
Publicado: (2011)

Multimodality imaging of indolent B cell lymphoma from diagnosis to transformation: what every radiologist should know
por: Alessandrino, Francesco, et al.
Publicado: (2019)

Immunotherapy in indolent Non-Hodgkin's Lymphoma
por: Amhaz, Ghid, et al.
Publicado: (2022)

Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
por: Blix, Egil S, et al.
Publicado: (2012)

Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features
por: Lim, Sojung, et al.
Publicado: (2022)

The role of local radiotherapy following rituximab‐containing chemotherapy in patients with transformed indolent B‐cell lymphoma
por: Nozaki, Kenji, et al.
Publicado: (2020)

P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report
por: Zerbi, Caterina, et al.
Publicado: (2022)

Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches
por: Nishimura, Midori Filiz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ud1v5o29ml1k0b0jacacg4qg0a